Derma Sciences Inc. (DSCI)
-NasdaqCM 13.81 
0.05(0.36%) 4:00PM EDT
| Prev Close: | 13.76 |
|---|
| Open: | 13.79 |
|---|
| Bid: | 10.50 x 300 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 17.00 |
|---|
| Beta: | 1.23 |
|---|
| Next Earnings Date: | 14-Aug-13 |
|---|
| Day's Range: | 13.52 - 13.85 |
|---|
| 52wk Range: | 8.80 - 14.92 |
|---|
| Volume: | 14,044 |
|---|
| Avg Vol (3m): | 38,943 |
|---|
| Market Cap: | 231.52M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -1.13 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Are Shorts Watching This Number at Derma Sciences?at Motley Fool(Thu 5:06PM EDT)
- DERMA SCIENCES, INC. FinancialsEDGAR Online Financials(Tue, May 21)
- Why Derma Sciences May Be About to Take Offat Motley Fool(Tue, May 21)
- DSCI January 2014 Options Begin Tradingat TheStreet(Mon, May 20)
- Company News for May 17, 2013Zacks(Fri, May 17)
- Derma Sciences' CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Thu, May 16)
- Derma Sciences Increases Sales but Misses Estimates on Earningsat Motley Fool(Thu, May 16)
- Derma Sciences takes bigger 1Q loss as costs growAP(Thu, May 16)
- Derma Sciences, Inc. Earnings Call scheduled for 11:00 am ET todayCCBN(Thu, May 16)
- Derma Sciences Reports First Quarter 2013 Financial ResultsBusiness Wire(Thu, May 16)
- Q1 2013 Derma Sciences, Inc. Earnings Release - Before Market OpenCCBN(Thu, May 16)
- DERMA SCIENCES, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, May 15)
- Derma Sciences to explore strategic options for DSC127 outside U.S.theflyonthewall.com(Tue, May 14)
- Derma Sciences Engages Plexus Ventures to Explore Strategic Options for DSC127 Outside the U.S.Business Wire(Tue, May 14)
- Insiders Opting Inat Seeking Alpha(Wed, May 8)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 3.03 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -1.69 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.46 |
|---|
| Mean Recommendation*: | 1.5 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Derma Sciences, Inc. operates as a medical technology company primarily in the United States and Canada. It operates in three segments: Advanced Wound Care, Traditional Wound Care, and Pharmaceutical Wound Care.
View More